Expression of Mrna of CYP11B2 in Patients with and Without Atrial Fibrillation
王学东,贾三庆,胡大一,杜立杰,陈金玲,吴永全,邢云丽
DOI: https://doi.org/10.3969/j.issn.1007-5410.2005.01.004
2005-01-01
Abstract:Objective This study was designed to analyze the mRNA expression of CYP11B2 in patients with and without atrial fibrillation (AF). Methods 38 patients who underwent opened thoracic surgery were enrolled. Of these cases, there were 18 males and 20 females.The average age was 51.92±14.00 years (18～77 years old).They were divided into 3 groups according to with or without history of AF:Sinus rhythm group (SR group, n=11); Paroxysmal AF group (pAF group , the duration of AF 6 months, n=13), Chronic AF group (cAF group , the duration of AF 6 months, n=14).The mRNA expression of CYP11B2 in atrial myocardium was determined by using Semi-Polymerase Chain Reaction (Semi-PCR). Results Compared with that of SR group and pAF group,the left atrial diameter of cAF group was significantly higher (78.8% and 37.5%, respectively, P0.01) and the level of mRNA of CYP11B2 in cAF patients was greatly increased (81% and 11.8%, respectively, P0.05～0.01). There was a positive correlation between the mRNA level of CYP11B2 and the size of left atrial diameter (P0.001,r=0.827). The value of left ventricular ejection fraction (LVEF) of cAF group was significantly lower than that of SR group(P0.05).Conclusion The tissue aldosterone must probably participated in the mediation of AF, and this role might be accomplished probably by promoting atrial structural remodeling.